The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma: The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym)

Table 2

Clinical characteristics of the sample at baseline.

Clinical characteristics	Patient sample (𝑁=84); 𝑁 (%)
NHL type
B Cell	77 (91.6%)
T Cell	5 (6.0%)
Other	1 (1.2%)
Missing	1 (1.2%)
NHL grade
Low	50 (59.5%)
Intermediate	22 (26.2%)
High	12 (14.3%)
Extent
Single site (excluding abdomen/mediastinum)	6 (7.1%)
Disease above the diaphragm (including mediastinum)	15 (17.9%)
Disease below the diaphragm (including GI disease)	21 (25.0%)
Disease on both sides of the diaphragm	19 (22.6%)
Any of the above with bone marrow or CNS involvement	22 (26.2%)
Missing	1 (1.2%)
Current active treatment?
Yes	71 (84.5%)
No	13 (15.5%)
Platelets, 1000/μL (𝑛=1 missing)
Mean	235.9
Range	16–834
SD	116.2
White blood cells (𝑛=1 missing)
Mean	6.3
Range	1–32
SD	4.3
Red blood cells (𝑛=1 missing)
Mean	4.1
Range	2.1–5.7
SD	0.7
Hemoglobin, g/dL (𝑛=1  missing)
Mean	12.7
Range	7–16
SD	1.9
Patient-rated ECOG PSR
0, normal activity	45 (53.6%)
1, some symptoms, no rest	33 (39.3%)
2, bed rest < 50% of day	6 (7.1%)
Physician-rated ECOG PSR
0, normal activity	42 (50.0%)
1, some symptoms, no rest	36 (42.8%)
2, bed rest < 50% of day	4 (4.8%)
Missing	2 (2.4%)